VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Gilead Sciences, Inc. vs Mettler-Toledo International Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Gilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisMettler-Toledo International Inc.
MTD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Mettler-Toledo International Inc.'s moat claims, evidence, and risks.
View MTD analysisComparison highlights
- Moat score gap: Gilead Sciences, Inc. leads (74 / 100 vs 73 / 100 for Mettler-Toledo International Inc.).
- Segment focus: Gilead Sciences, Inc. has 5 segments (68.5% in HIV); Mettler-Toledo International Inc. has 3 segments (56% in Laboratory Products and Services).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Gilead Sciences, Inc. has 8 moat types across 3 domains; Mettler-Toledo International Inc. has 5 across 3.
Primary market context
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Mettler-Toledo International Inc.
Laboratory Products and Services
Laboratory precision weighing (balances/scales) and adjacent lab measurement & sample-prep instruments, plus related software and services
Global
Life science, chemical, academic, and testing laboratories (end-users) via direct sales and distributors
Instrument OEM / software provider / service provider
56%
Side-by-side metrics
Moat coverage
Shared moat types
Gilead Sciences, Inc. strengths
Mettler-Toledo International Inc. strengths
Segment mix
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Mettler-Toledo International Inc. segments
Full profile >Laboratory Products and Services
Oligopoly
Industrial Products and Services
Competitive
Food Retailing Products and Services
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.